Antiplatelet drugs, particularly aspirin, may be effective in reducing the incidence of stroke in patients at risk from cardiogenic emboli. Aspirin in combination with low intensive oral anticoagulation, particularly, warfarin, may be even more beneficial. Anticoagulation to INR's of 2-3 appears effective in those with non-valvular atrial fibrillation.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page